STOCKSCOPE

Centaurus Metals (ASX: CTM) Secures A$17.8 Million from Glencore, but Can It Fund Jaguar's US$380 Million Development?

Mark Elzayed

Mark Elzayed

CIO at Vestra Capital

Published:5d ago
Centaurus Metals (ASX: CTM) Secures A$17.8 Million from Glencore, but Can It Fund Jaguar's US$380 Million Development?

Centaurus Metals Limited (ASX: CTM) has strengthened its position in the global nickel market, securing A$17.8 million from Glencore as part of a broader US$40 million strategic investment package.

With approximately US$900 million in estimated nickel concentrate sales covered by two new offtake agreements, the Jaguar Nickel Project in Brazil has gained significant commercial momentum.

But one question remains: can Centaurus secure enough funding to turn its promising nickel asset into a profitable operation?

Key numbers

  • A$17.8 million: Initial Glencore investment completed through the issue of 41.9 million shares at A$0.425 each.
  • US$40 million: Combined strategic equity commitments from Glencore and CNGR, including conditional second tranches.
  • US$900 million: Estimated net sales value of the two new five-year nickel concentrate offtake agreements at prevailing nickel prices.
  • US$380 million: Estimated pre-production capital expenditure for Jaguar under the May 2025 value engineering study.
  • A$11.07 million: Cash reserves at 30 September 2026, before the strategic placements.

Glencore's Investment Brings Jaguar Closer to Development

On 3 November 2026, Centaurus confirmed completion of Glencore's initial US$12.5 million equity investment, equivalent to approximately A$17.8 million.

The placement involved 41,903,070 shares issued at A$0.425 each, representing a 5% premium to the preceding 20-day volume-weighted average price.

Glencore and CNGR Advanced Material have each committed US$20 million across two tranches.

Their remaining US$7.5 million contributions depend on shareholder approval and a final investment decision (FID), with CNGR also requiring Chinese regulatory approval.

The agreements secure buyers for Jaguar's forecast nickel concentrate production during its first five operating years, targeting commencement in 2029.

However, contracted production does not guarantee revenue. Actual sales depend on construction, delivery volumes and nickel prices.

US$900 Million Sales Potential Meets a Funding Challenge

The two new offtake agreements carry an estimated combined net sales value of US$900 million over five years, based on nickel prices prevailing when the agreements were announced.

Pricing remains linked to London Metal Exchange nickel benchmarks, meaning future revenue could fluctuate significantly.

Importantly, both customers can terminate their respective agreements if initial concentrate shipments have not occurred by the end of 2029.

Jaguar's May 2025 value engineering study estimated a post-tax net present value of A$1.15 billion using an 8% discount rate, alongside a 34% internal rate of return.

Those economics assumed nickel prices averaging US$19,800 per tonne.

The combined US$40 million strategic commitments represent approximately 10.5% of estimated pre-production capital expenditure, leaving substantial funding requirements.

Centaurus reported A$2.74 million in net operating cash outflows and A$6.77 million in investing outflows during the September quarter.

Although strategic funding improves liquidity, construction will require substantially greater capital.

What Centaurus Is Doing Now

Centaurus is progressing Jaguar's engineering, construction preparation and senior debt negotiations.

Recent activities include completing geotechnical drilling, securing electricity grid access and executing a power transmission agreement.

Independent technical and environmental assessments have also supported discussions with shortlisted financiers.

Beyond Jaguar, the company continues evaluating copper-gold exploration opportunities at its Boi Novo Project.

However, Jaguar remains the primary driver of Centaurus' potential future revenue and cash generation.

Insight: Can Strategic Backing Justify Jaguar's Valuation?

We think Glencore and CNGR's commitments materially strengthen Jaguar's commercial credibility, particularly because both groups have established downstream nickel operations. Securing customers for forecast production reduces sales uncertainty, but it does not eliminate commodity-price exposure or development risk. Jaguar's A$1.15 billion modelled project valuation appears attractive relative to its estimated development expenditure, although construction costs, financing terms and dilution could materially reduce shareholder value. The decisive test is whether Centaurus can secure binding debt financing on terms that preserve the project's economic potential without placing excessive pressure on existing shareholders.

What Happens Next?

Centaurus is targeting progress towards completing senior debt financing during the December 2026 quarter, following earlier expectations of an FID in the September quarter.

The remaining strategic equity tranches are subject to conditions with a 31 January 2027 deadline.

Binding debt commitments, confirmation of CNGR's initial placement and an FID would represent significant development milestones.

For Centaurus, commercial demand is becoming clearer. The bigger challenge is demonstrating that Jaguar can be financed, constructed and operated profitably before its contractual delivery deadlines become a constraint.

Mark Elzayed

Mark Elzayed

(CIO at Vestra Capital)

Mark Elzayed is a prominent Australian financial executive and portfolio strategist with over a decade of hands-on capital markets experience. Having successfully managed over $100M+ in FUM across volatile economic cycles, Mark founded Vestra Capital to democratize institutional-grade quantitative strategies and privileged ASX deal flow for Australian investors.

DisclaimerInformation on Stockscope is general in nature and does not constitute financial product advice. It does not take into account your personal objectives, financial situation or needs. Seek independent advice from a qualified financial adviser before making an investment decision. Stockscope and its affiliates do not guarantee the accuracy or completeness of information published on this website. To the extent permitted by law, they accept no liability for any claim, loss or damage arising from its use or reliance on it. Stockscope and its associates may have commercial relationships with companies featured on this website, hold securities in those companies, or receive commissions in connection with capital raisings.

Continue Reading

ASX Weathers Wall Street's AI Rout, but Three Market Risks Are Becoming Harder to Ignore
Market Briefings
Market Briefings

ASX Weathers Wall Street's AI Rout, but Three Market Risks Are Becoming Harder to Ignore

Australian equities: what moved the ASX 200? Australian shares finished lower on Friday, 6 November, as the technology-led sell-off on Wall Street spread across global markets. The ASX 200...

Mark ElzayedMark Elzayed•
Epiminder (ASX: EPI) Expands FDA Clearance as $65 Million Cash Reserve Faces a Crucial Commercial Test
Biotech & Health
Biotech & Health

Epiminder (ASX: EPI) Expands FDA Clearance as $65 Million Cash Reserve Faces a Crucial Commercial Test

Epiminder Limited ASX: EPI has expanded the US market for its epilepsy monitoring technology following a significant regulatory clearance, strengthening its commercial prospects ahead of a p...

Danny AadDanny Aad•
Asara Resources (ASX: AS1) Hits 38m at 2.1g/t Gold: Could Sogosogoba Unlock Kada's Next Growth Phase?
Mining
Mining

Asara Resources (ASX: AS1) Hits 38m at 2.1g/t Gold: Could Sogosogoba Unlock Kada's Next Growth Phase?

A 38-metre gold intersection grading 2.1 grams per tonne has given Asara Resources Limited ASX: AS1 an encouraging exploration result beyond its established Massan deposit in Guinea. The dis...

Alison ElzayedAlison Elzayed•
Alvo Minerals (ASX: ALV) Expands Rare Earth Discovery Across 6.5km², but Can It Deliver Economic Value?
Mining
Mining

Alvo Minerals (ASX: ALV) Expands Rare Earth Discovery Across 6.5km², but Can It Deliver Economic Value?

Alvo Minerals Limited ASX: ALV has extended rare earth mineralisation approximately 2 kilometres beyond previously tested areas at its Boa Vista prospect in Brazil, strengthening the explora...

Alison ElzayedAlison Elzayed•
Avenira Limited (ASX: AEV) Raises $48.9 Million as Wonarah Phosphate Project Faces Its Biggest Test Yet
Mining
Mining

Avenira Limited (ASX: AEV) Raises $48.9 Million as Wonarah Phosphate Project Faces Its Biggest Test Yet

Avenira Limited ASX: AEV has reached a significant financing milestone, with its $48.9 million rights issue providing fresh capital to advance the Wonarah Phosphate Project in the Northern T...

Alison ElzayedAlison Elzayed•
Mayne Pharma Group (ASX: MYX) Unveils $55.5 Million Sale, but Can Its US Business Deliver Stronger Profits?
Biotech & Health
Biotech & Health

Mayne Pharma Group (ASX: MYX) Unveils $55.5 Million Sale, but Can Its US Business Deliver Stronger Profits?

Mayne Pharma Group Limited ASX: MYX is taking a decisive step towards becoming a US-focused pharmaceutical company, agreeing to sell its international operations for $55.5 million. The tran...

Danny AadDanny Aad•
Loading more stories...